Search Within

Charles Rudin

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (15)
  2. Department of Medicine (15)
  3. GSK Faculty (15)
  4. Molecular Pharmacology and Chemistry Program Faculty (15)
  5. Sloan Kettering Institute Faculty (15)
  6. Solid Tumor Oncology Division (15)

More Groups

People
  1. Neal Rosen (6)
  2. Elisa De Stanchina (4)
  3. John Poirier (4)
  4. Pat Zanzonico (4)
  5. Barney Yoo (3)
  6. Brian Madajewski (3)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (3)
  4. 2020 (4)
  5. 2019 (1)
  6. 2016 (2)

More Years

Publications
  1. Clinical Cancer Research (5)
  2. Cancer Discovery (2)
  3. Cell Reports (1)
  4. Immunity (1)
  5. JTO Clinical and Research Reports (1)
  6. Journal of Nuclear Medicine (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. Cell Press (3)
  3. American Association for the Advancement of Science (1)
  4. Elsevier BV (1)
  5. Elsevier Inc. (1)
  6. Nature Publishing Group (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
    Journal Article

    Su, W.; Mukherjee, R.; Yaeger, R.; Son, J.; Xu, J.; Na, N.; Timaul, N. M.; Hechtman, J.; Paroder, V.; Lin, M.; more...
    Molecular Cell (2022)

    Fulltext@MSK | Save
  • Ultrasmall nanoparticle delivery of doxorubicin improves therapeutic index for high-grade glioma
    Journal Article

    Aragon-Sanabria, V.; Aditya, A.; Zhang, L.; Chen, F.; Yoo, B.; Cao, T.; Madajewski, B.; Lee, R.; Turker, M. Z.; Ma, K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase 1 clinical trial of trametinib and ponatinib in patients with NSCLC harboring KRAS mutations
    Journal Article

    Arbour, K. C.; Manchado, E.; Bott, M. J.; Ahn, L.; Tobi, Y.; Ni, A. A.; Yu, H. A.; Shannon, A.; Ladanyi, M.; Perron, V.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; RivieĢ€re, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • KRAS(G12C) mutation is associated with increased risk of recurrence in surgically resected lung adenocarcinoma
    Journal Article

    Jones, G. D.; Caso, R.; Tan, K. S.; Mastrogiacomo, B.; Sanchez-Vega, F.; Liu, Y.; Connolly, J. G.; Murciano-Goroff, Y. R.; Bott, M. J.; Adusumilli, P. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • A self-assembling and disassembling (SADA) bispecific antibody (BsAb) platform for curative two-step pretargeted radioimmunotherapy
    Journal Article

    Santich, B. H.; Cheal, S. M.; Ahmed, M.; McDevitt, M. R.; Ouerfelli, O.; Yang, G.; Veach, D. R.; Fung, E. K.; Patel, M.; Burnes Vargas, D.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Molecular engineering of ultrasmall silica nanoparticle-drug conjugates as lung cancer therapeutics
    Journal Article

    Madajewski, B.; Chen, F.; Yoo, B.; Turker, M. Z.; Ma, K.; Zhang, L.; Chen, P. M.; Juthani, R.; Aragon-Sanabria, V.; Gonen, M.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Self-Assembling and DisAssembling bispecific antibodies for curative 2-step pretargeted radioimmunotherapy
    Meeting Abstract

    Santich, B.; Cheal, S.; Ahmed, M.; McDevitt, M.; Ouerfelli, O.; Veach, D.; Fung, E.; Burnes Vargas, D.; Malik, A.; Guo, H. F.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers
    Journal Article

    Li, B. T.; Michelini, F.; Misale, S.; Cocco, E.; Baldino, L.; Cai, Y.; Shifman, S.; Tu, H. Y.; Myers, M. L.; Xu, C.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save